Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMST01020005 | CE(16:0) | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 35.3 | pmol/sample |
| LMST01020005 | CE(16:0) | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 49.4 | pmol/sample |
| LMST01020005 | CE(16:0) | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 39.6 | pmol/sample |
| LMST01020005 | CE(16:0) | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 57 | pmol/sample |
| LMST01020005 | CE(16:0) | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 39.2 | pmol/sample |
| LMST01020005 | CE(16:0) | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 37.6 | pmol/sample |
| LMST01020005 | CE(16:0) | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 34.4 | pmol/sample |
| LMST01020005 | CE(16:0) | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 13.2 | pmol/sample |
| LMST01020005 | CE(16:0) | C | 0.0 | BCD100322A01 | 44.2 | pmol/sample |
| LMST01020005 | CE(16:0) | C | 0.5 | BCD100322A03 | 76.1 | pmol/sample |
| LMST01020005 | CE(16:0) | C | 1.0 | BCD100322A07 | 85.7 | pmol/sample |
| LMST01020005 | CE(16:0) | C | 2.0 | BCD100322A11 | 87.3 | pmol/sample |
| LMST01020005 | CE(16:0) | C | 4.0 | BCD100322A15 | 36.9 | pmol/sample |
| LMST01020005 | CE(16:0) | C | 8.0 | BCD100322A19 | 85.2 | pmol/sample |
| LMST01020005 | CE(16:0) | C | 12.0 | BCD100322A23 | 84.1 | pmol/sample |
| LMST01020005 | CE(16:0) | C | 24.0 | BCD100322A27 | 32.1 | pmol/sample |
| LMST01020005 | CE(16:0) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 50.1 | pmol/sample |
| LMST01020005 | CE(16:0) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 75.4 | pmol/sample |
| LMST01020005 | CE(16:0) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 84.1 | pmol/sample |
| LMST01020005 | CE(16:0) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 138 | pmol/sample |
| LMST01020005 | CE(16:0) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 202 | pmol/sample |
| LMST01020005 | CE(16:0) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 143 | pmol/sample |
| LMST01020005 | CE(16:0) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 141 | pmol/sample |
| LMST01020005 | CE(16:0) | 25OH-Chol | 0.5 | BCD100322A04 | 71.5 | pmol/sample |
| LMST01020005 | CE(16:0) | 25OH-Chol | 1.0 | BCD100322A08 | 54.9 | pmol/sample |
| LMST01020005 | CE(16:0) | 25OH-Chol | 2.0 | BCD100322A12 | 111 | pmol/sample |
| LMST01020005 | CE(16:0) | 25OH-Chol | 4.0 | BCD100322A16 | 95.7 | pmol/sample |
| LMST01020005 | CE(16:0) | 25OH-Chol | 8.0 | BCD100322A20 | 123 | pmol/sample |
| LMST01020005 | CE(16:0) | 25OH-Chol | 12.0 | BCD100322A24 | 129 | pmol/sample |
| LMST01020005 | CE(16:0) | 25OH-Chol | 24.0 | BCD100322A28 | 81.6 | pmol/sample |